Wyeth (WYE) Inactive 10-Q2007 Q3 Quarterly report

Filed: 7 Nov 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: acetate, acknowledged, acute, Agent, andDIMETAPP, andDIMETAPPfamily, andWolfe, ANYA, argument, arrive, asPREMPRO, awaiting, back, Bank, begun, BENEFIXand, bioequivalence, bond, Boston, Bruce, buildup, capsule, CDC, Chase, CHMP, Citicorp, Citigroup, clarify, clear, closer, closure, combinedEFFEXORandEFFEXOR, community, confidence, contaminated, contending, convincing, cough, criminal, currentPREMPRO, Daniel, deliberate, denial, deposition, dialogue, died, Director, DPP, Dr, Dublin, duly, duty, emphasized, enantiomer, enjoined, epidemiological, erroneously, Exhibit, extraordinary, fiduciary, Finland, Fixed, forANYA, forAPRELA, forEFFEXOR, forLYBRELin, forPROTONIX, forPROTONIXand, forTORISELandLYBREL, forZOSYNin, fromALTACEwill, GmbH, ground, heard, Hennepin, High, imposition, inColeman, inRowatt, instructed, inventor, inZandi, Irish, Japanese, jointly, JPMorgan, Justice, knowingly, level, lost, Medica, Medicinal, medroxyprogesterone, Medtronic, metabolism, Minnesota, Morgan, mutual, negotiation, Nevada, Newbridge, Nonprescription, Nova, NV, ofDaniel, ofINDERAL, ofTAZOCIN, older, Ontario, opine, ordinarily, ourROBITUSSIN, path, Paul, pendency, Pollution, Portugal, preclude, procedure, proceed, proffered, prognostic, prosecute, prosecution, question, ratiopharm, recanted, redesign, rejected, reversal, Rowatt, Saffran, Scotia, served, sooner, Spain, stable, statute, subsidiary, substitutable, successful, sued, sugar, Superior, supplementary, suspended, Syndication, TAZOCINinternationally, testimony, theColeman, theDaniel, thePREVENARlabeling, therapeutically, thereunto, theROBITUSSIN, thrombotic, toEFFEXOR, UBS, undersigned, unknown, unspecified, vacated, vacatur, vast, virtually, warranted, Washoe, waste, water, withdrawal, WMI, Wolfe, writ, wrongfully

Removed: assessing, closed, closing, concert, consultant, defendant, elimination, expanding, free, hiring, independent, leadership, LYBREL, North, noted, Office, oversight, ownership, presence, reinforce, reorganization, retailer, standard, stay, supplement, training, utilizing, Warning

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

WYE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 10.1

AMENDMENT TO

THE WYETH 2005 AMENDED AND RESTATED STOCK INCENTIVE PLAN

Effective as of September 27, 2007, the Wyeth 2005 Amended and Restated Stock Incentive Plan was amended as follows:

Section 7 was amended to read in its entirety as follows:

Section 7.Adjustment in Event of Change in Stock. Subject to Section 8, in the event of a stock split, stock dividend, cash dividend (other than a regular cash dividend), combination of shares, merger, or other relevant change in the Company’s capitalization, the Committee shall adjust in the manner determined by the Committee in its sole discretion to be appropriate (i) the number and kind of shares available for issuance under the Plan (including the number of shares that may be granted as Restricted Stock), (ii) the maximum number of shares for which Options may be granted to any Participant during any one fiscal year of the Company, (iii) the number, kind and Option Price of shares subject to outstanding Options and/or (iv) the number and kind of shares subject to outstanding Restricted Stock awards; provided, however, that, except in the case of incentive stock options, the number, kind and Option Price of shares subject to outstanding Options shall be adjusted in the manner described in Section 1.409A-1(b)(5)(v)(D) of the Treasury Regulations;provided,further, that the case of incentive stock options, to the extent permitted by Sections 422 and 424 of the Code, in the event that the outstanding shares of Common Stock of the Company are increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company or of another corporation, through reorganization, merger, consolidation, liquidation, recapitalization, reclassification, stock split-up, combination of shares or dividend, appropriate adjustment in the number and kind of shares as to which Options may be granted and as to which Options or portions thereof then unexercised shall be exercisable, and in the Option Price thereof, shall be made to the end that the proportionate number of shares or other securities as to which Options may be granted and the Participant’s proportionate interests under outstanding Options shall be maintained as before the occurrence of such event;provided, that any such adjustment in shares subject to outstanding Options (including any adjustments in the Option Price) shall be made in such manner as not to constitute a modification as defined by subsection (h)(3) of Section 424 of the Code; andprovided,further, that, in the event of an adjustment in the number or kind of shares under a Restricted Stock award pursuant to this Section 7, any new shares or units issued to the Participant in respect thereof shall be subject to the same terms, conditions and restrictions as the underlying Restricted Stock award for which the adjustment was made.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.